Hogan Lovells Publications
A new year, a new disclosure: ICMJE requires registrations for clinical trials beginning in 2019 to include disclosure of data sharing plan Pharmaceutical and Biotechnology Alert
14 February 2019
Senior AssociateLos Angeles
Email bert.lao@hoganlovells.com
Phone +1 310 785 4712
Fax +1 310 785 4601
Practice groupGlobal Regulatory
To realize your goals in the life sciences sector, an understanding of the regulatory intricacies of the U.S Food and Drug Administration (FDA) can be crucial. Bert Lao, a senior associate in our Pharmaceutical and Biotechnology practice, provides guidance to clients on a broad array of topics as they navigate one of the most heavily regulated industries in the United States.
Bert has counseled innovator pharmaceutical and biotechnology companies, investment groups, and contract research organizations on matters ranging from new drug approval to advertising and promotion compliance. With a background in biomedical engineering, Bert offers an interdisciplinary perspective on legal challenges that can become heavily intertwined with underlying scientific issues.
Rising Stars, Food & Drugs
Los Angeles Super Lawyers
Education
J.D., University of California, Berkeley School of Law, 2011
Ph.D., University of California, Los Angeles, 2008
B.S., University of California, San Diego, 2003
Bar admissions and qualifications
California
Court admissions
Supreme Court of California
Hogan Lovells Publications
14 February 2019
Blog Post
05 November 2018
Hogan Lovells Publications
25 September 2018
Blog Post
09 October 2017
Publications
21 August 2017
Hogan Lovells Publications
27 June 2017